GIP
JAZZ icon

Granite Investment Partners’s Jazz Pharmaceuticals JAZZ Stock Holding History

Granite Investment Partners’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$332K Buy
1,757
+212
+14% +$37K 0.02% 208
2025
Q4 		$263K Sell
1,545
-7,630
-83% -$1.17M 0.02% 218
2025
Q3 		$1.21M Sell
9,175
-9,309
-50% -$1.12M 0.07% 188
2025
Q2 		$1.96M Sell
18,484
-3,037
-14% -$330K 0.1% 177
2025
Q1 		$2.67M Buy
+21,521
New +$2.81M 0.14% 168
2023
Q2 		– Sell
-36,983
Closed -$5.41M – 267
2023
Q1 		$5.41M Buy
+36,983
New +$5.47M 0.23% 132

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Granite Investment Partners's JAZZ Position: Q1 2026 in Review

Granite Investment Partners increased its Jazz Pharmaceuticals (JAZZ) stake by 14% in Q1 2026, buying an estimated $37K and bringing the position to 1,757 shares worth $332K. The position accounts for 0.02% of the portfolio, ranked #208.

Granite Investment Partners first reported a position in JAZZ in Q1 2023 and has held it in 6 quarters since. The position peaked at $5.41M in Q1 2023. 571 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Granite Investment Partners held 1,757 shares of Jazz Pharmaceuticals worth $332K as of Q1 2026.
  • Granite Investment Partners bought 212 Jazz Pharmaceuticals shares in Q1 2026, an estimated $37K.
  • Jazz Pharmaceuticals made up 0.02% of Granite Investment Partners's portfolio in Q1 2026, its #208 holding.
  • Granite Investment Partners first reported a position in Jazz Pharmaceuticals in Q1 2023 and has held it in 6 quarters since.
  • Granite Investment Partners's Jazz Pharmaceuticals position peaked at $5.41M in Q1 2023.
  • 571 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Granite Investment Partners's 13F filing for Q1 2026, filed 30 Apr 2026.